Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Celecoxib Capsule Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Celecoxib Capsule Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 50mg
    • 1.2.3 100mg
    • 1.2.4 200mg
    • 1.2.5 400mg
  • 1.3 Market by Application
    • 1.3.1 Global Celecoxib Capsule Market Share by Application: 2020 VS 2026
    • 1.3.2 Rheumatoid Arthritis
    • 1.3.3 Osteoarthritis
    • 1.3.4 Acute Pain
    • 1.3.5 Musculoskeletal Pain
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Celecoxib Capsule Market Perspective (2015-2026)
  • 2.2 Global Celecoxib Capsule Growth Trends by Regions
    • 2.2.1 Celecoxib Capsule Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Celecoxib Capsule Historic Market Share by Regions (2015-2020)
    • 2.2.3 Celecoxib Capsule Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Celecoxib Capsule Players by Market Size
    • 3.1.1 Global Top Celecoxib Capsule Players by Revenue (2015-2020)
    • 3.1.2 Global Celecoxib Capsule Revenue Market Share by Players (2015-2020)
  • 3.2 Global Celecoxib Capsule Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Celecoxib Capsule Revenue
  • 3.4 Global Celecoxib Capsule Market Concentration Ratio
    • 3.4.1 Global Celecoxib Capsule Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Celecoxib Capsule Revenue in 2019
  • 3.5 Key Players Celecoxib Capsule Area Served
  • 3.6 Key Players Celecoxib Capsule Product Solution and Service
  • 3.7 Date of Enter into Celecoxib Capsule Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Celecoxib Capsule Breakdown Data by Type (2015-2026)

  • 4.1 Global Celecoxib Capsule Historic Market Size by Type (2015-2020)
  • 4.2 Global Celecoxib Capsule Forecasted Market Size by Type (2021-2026)

5 Celecoxib Capsule Breakdown Data by Application (2015-2026)

  • 5.1 Global Celecoxib Capsule Historic Market Size by Application (2015-2020)
  • 5.2 Global Celecoxib Capsule Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Celecoxib Capsule Market Size (2015-2026)
  • 6.2 North America Celecoxib Capsule Market Size by Type (2015-2020)
  • 6.3 North America Celecoxib Capsule Market Size by Application (2015-2020)
  • 6.4 North America Celecoxib Capsule Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Celecoxib Capsule Market Size (2015-2026)
  • 7.2 Europe Celecoxib Capsule Market Size by Type (2015-2020)
  • 7.3 Europe Celecoxib Capsule Market Size by Application (2015-2020)
  • 7.4 Europe Celecoxib Capsule Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Celecoxib Capsule Market Size (2015-2026)
  • 8.2 China Celecoxib Capsule Market Size by Type (2015-2020)
  • 8.3 China Celecoxib Capsule Market Size by Application (2015-2020)
  • 8.4 China Celecoxib Capsule Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 India

  • 9.1 India Celecoxib Capsule Market Size (2015-2026)
  • 9.2 India Celecoxib Capsule Market Size by Type (2015-2020)
  • 9.3 India Celecoxib Capsule Market Size by Application (2015-2020)
  • 9.4 India Celecoxib Capsule Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Celecoxib Capsule Market Size (2015-2026)
  • 10.2 Southeast Asia Celecoxib Capsule Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Celecoxib Capsule Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Celecoxib Capsule Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Details
    • 11.1.2 Pfizer Business Overview
    • 11.1.3 Pfizer Celecoxib Capsule Introduction
    • 11.1.4 Pfizer Revenue in Celecoxib Capsule Business (2015-2020))
    • 11.1.5 Pfizer Recent Development
  • 11.2 Teva
    • 11.2.1 Teva Company Details
    • 11.2.2 Teva Business Overview
    • 11.2.3 Teva Celecoxib Capsule Introduction
    • 11.2.4 Teva Revenue in Celecoxib Capsule Business (2015-2020)
    • 11.2.5 Teva Recent Development
  • 11.3 Mylan
    • 11.3.1 Mylan Company Details
    • 11.3.2 Mylan Business Overview
    • 11.3.3 Mylan Celecoxib Capsule Introduction
    • 11.3.4 Mylan Revenue in Celecoxib Capsule Business (2015-2020)
    • 11.3.5 Mylan Recent Development
  • 11.4 Apotex
    • 11.4.1 Apotex Company Details
    • 11.4.2 Apotex Business Overview
    • 11.4.3 Apotex Celecoxib Capsule Introduction
    • 11.4.4 Apotex Revenue in Celecoxib Capsule Business (2015-2020)
    • 11.4.5 Apotex Recent Development
  • 11.5 Lupin
    • 11.5.1 Lupin Company Details
    • 11.5.2 Lupin Business Overview
    • 11.5.3 Lupin Celecoxib Capsule Introduction
    • 11.5.4 Lupin Revenue in Celecoxib Capsule Business (2015-2020)
    • 11.5.5 Lupin Recent Development
  • 11.6 HENGRUI MEDICINE
    • 11.6.1 HENGRUI MEDICINE Company Details
    • 11.6.2 HENGRUI MEDICINE Business Overview
    • 11.6.3 HENGRUI MEDICINE Celecoxib Capsule Introduction
    • 11.6.4 HENGRUI MEDICINE Revenue in Celecoxib Capsule Business (2015-2020)
    • 11.6.5 HENGRUI MEDICINE Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankylosing spondylitis, painful menstruation, and juvenile rheumatoid arthritis. It may also be used to decrease the risk of colorectal adenomas in people with familial adenomatous polyposis. It is taken by mouth. Benefits are typically seen within an hour.
    Market Analysis and Insights: Global Celecoxib Capsule Market
    The global Celecoxib Capsule market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Celecoxib Capsule market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Celecoxib Capsule market in terms of revenue.
    On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Celecoxib Capsule market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Celecoxib Capsule market.
    Celecoxib Capsule Breakdown Data by Type
    50mg
    100mg
    200mg
    400mg
    Celecoxib Capsule Breakdown Data by Application
    Rheumatoid Arthritis
    Osteoarthritis
    Acute Pain
    Musculoskeletal Pain
    Others
    Based on regional and country-level analysis, the Celecoxib Capsule market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    In the competitive analysis section of the report, leading as well as prominent players of the global Celecoxib Capsule market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The following players are covered in this report:
    Pfizer
    Teva
    Mylan
    Apotex
    Lupin
    HENGRUI MEDICINE
    Buy now